Company: Cipla Ltd. Category: Company News

The EIR received following the inspection carried by the United States Food and Drug Administration (USFDA) at the facility from March 11, 2019, to March 20, 2019.
June 10, 2019, 3:02 p.m.

Shares of Biocon, which dropped 3%, were leading the indexs fall.
June 7, 2019, 12:07 p.m.

Drug firm Cipla said it is looking at continued growth across all its key markets in the current fiscal year and plans to file over 12 abbreviated ne
May 26, 2019, 3:08 p.m.

Total revenue from operations for the last fiscal stood at Rs 16,362.41 crore. It was Rs 15,219.25 crore in the preceding financial year
May 26, 2019, 11:20 a.m.

Post-acquisition, AMP Solar will become an associate of Cipla Limited.
May 24, 2019, 8:24 a.m.

Check out the companies which will be in focus during trade today based on recent and latest news developments.
May 24, 2019, 8:07 a.m.

Higher competitive intensity, increasing investments, and moderate growth could weigh on returns
May 23, 2019, 12:09 a.m.

The consolidated net sales rose 22% to ₹4,271 crore.The company's board recommends a dividend of ₹3 per share
May 22, 2019, 1:55 p.m.

Drug major Cipla on Tuesday said it has received final approval from the United States Food and Drug Administration (USFDA) for Ambrisentan tablets,
April 30, 2019, 12:41 p.m.

The USFDA has classified both the recalls as a Class-II recall
April 28, 2019, 12:50 p.m.